title: Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis.
authors.forename: Elio
authors.initials: E
authors.lastname: Castagnola
authors.forename: Barbara
authors.initials: B
authors.lastname: Cappelli
authors.forename: Maura
authors.initials: M
authors.lastname: Faraci
authors.forename: Stefania
authors.initials: S
authors.lastname: Fallani
authors.forename: Maria Iris
authors.initials: MI
authors.lastname: Cassetta
authors.forename: Andrea
authors.initials: A
authors.lastname: Novelli
mesh_terms: D000293:Adolescent; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D002851:Chromatography, High Pressure Liquid; D054714:Echinocandins / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D055666:Lipopeptides
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin